The manuscript should be typed, double-spaced on standard A4 sized paper (8.5" x 11") with 1" margins on all sides. Times New Roman font 12 pt should be used. The fonts used in the text, as well as graphics, should be restricted to Times New Roman, Symbol and Zapf Dingbats.
The title page should contain a clear, concise, and informative title of the article followed by the names and affiliations of the authors. The affiliation should comprise the department, institution, city, and state (or nation) and should be typed as a footnote to the author's name. The Corresponding Author must indicate his or her complete mailing address, office/cellular phone number, fax number, and email address at the lower left of the Title Page.
The abstract should not more than 200 words and should provide brief details about objectives of study, materials and methods, Results and Conclusions. The abstract should not be structured, it should be a single paragraph without subheadings. The abstract must be followed by four-six keywords.
This should be brief and indicates the aim of the study and the essential background information. The introduction should clearly state the hypothesis or purpose statement, how and why the purpose or hypothesis was developed and why the author deems it important.
Materials and methods
Please provide concise but complete information about the material and the analytical, statistical, and experimental procedures used. This part should be as clear as possible to enable other scientists to repeat the research presented. The use of subheadings to divide the text is encouraged. Primary headings should be in BOLD CAPITAL LETTERS. Secondary or subheadings should be in Bold sentence case. Third level subheadings should be in Italicized sentence Case. In the case of animal/human experiments or clinical trials, authors must give the details of ethical approval.
Result and Discussion
Data acquired from the research with the appropriate statistical analysis described in the methods section should be included in this section. In this part, the same data/ information given in a table must not be repeated in a figure or vice versa. Tables and Figures should be self-explanatory and it is not acceptable to repeat extensively the numerals from tables into text and give lengthy and unnecessary explanations of the Tables and Figures. The discussion should relate the results to the current understanding of the scientific problems being investigated in the field.
This should clearly explain the main conclusions of the work highlighting its importance and relevance.
Reference should be cited in the text by the author’s last name & year.
Single author: the author's name (without initials) and the year of publication eg. (Martin, 2009). Two authors: The last name of both the authors and year of publication should be used i.e. (Mishra and Ahmed, 2010). Three or more authors: first author's name followed by et al and year of publication i.e. (Das et al., 2012).
References should be arranged in alphabetical order and further shorted in a chronological manner.
Wahyuni W, Fristiohady A, Malaka MH, Malik F, Yusuf MI, Leorita M, Sadarun B, Saleh A, Musnina WOS, Sabandar CW, Sahidin I. Effects of Indonesian marine sponges ethanol extracts on the lipid profile of hyperlipidemic rats. J Appl Pharm Sci, 2019; 9(10):001-008.
Reference to a book:
Vyas SP, Khar RK. 2001. Targeted and controlled drug delivery. New Delhi, India: CBS Publisher and Distributor.
Chapter in an edited book:
Chandrasekaran SK, Benson H, Urquhart J. 1978. Methods to achieve controlled drug delivery: The biomedical engineering approach. In: Robinson JR, ed. Sustained and Controlled Release Drug Delivery Systems. New York: Marcel Dekker 557-93.
Webpage with authors
Anchal Sankhyan and Pravin Pawar. 2012. Recent Trends in Niosome as Vesicular Drug Delivery
System. [ONLINE] Available at: http://www.japsonline.com/counter.php=497. [Accessed 08 July 2012].
Webpage without authors
How to cite web reference. 2011. Available at: http://www.japsonline.com/authors-guidelines.php [Accessed 08 July 2012].
Webpage with no date:
How to cite web reference. Available at: http://www.japsonline.com/authors-guidelines.php [Accessed 08 July 2012].
TABLES & FIGURES
Tables and figures should not be embedded in the text, but should be included at the end of the manuscript on separate pages. Tables should be created with a word processor and cited consecutively in the text. To ensure the highest print quality, your figures must be submitted in TIF/JPG/JPEG format with minimum 300 dpi or higher resolutions. Captions/legends will be placed below figures and adjusted to 10 font size.
Authors are required to submit a graphical abstract, in single JPEG/TIF image that visually represents the key findings of your article. The graphical abstracts will appear at the cover page of the online version of the article. It should constitute a single image without a separate legend as per following specifications;
- Graphical Abstracts should be submitted as a single high-resolution (300 dpi or greater) image file; preferred file types are .tif, .jpeg, or .png
- Please lable the file clearly as 'Graphical Abstract'.
- Font: Please use Arial, Times New Roman, or Symbol font in 8 pt, with 5 pt for sub- and superscript. Lines and strokes should be between 0.5 and 1 pt.
- Colors: The use of color is encouraged. Color figures should be in RGB format.
AUTHORSHIP AND ACKNOWLEDGEMENTS
All the authors in a manuscript are equally responsible for the technical information communicated to the journal. Thus, it is necessary that all authors must read and approve the final version of the manuscript before submitting it to the journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper and all must have critically reviewed its content and have approved the final version submitted for publication. Participation solely in the acquisition of funding or the collection of data does not justify authorship.
JAPS follows the definition of authorship given by the International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
- Drafting the work or revising it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authors should meet all the four conditions. Please click here to download the Authorship Contribution Form, authors are required to upload the duly filled and signed form under the additional files section, during manuscript submission. They can also send it by email to email@example.com. In addition to that, all the manuscripts should contain Authors’ Contributions statement immediately before the Acknowledgments section.
All acknowledgments should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth. Contributors who do not qualify as authors should be mentioned under Acknowledgements.
CONFLICT OF INTEREST
All the authors must disclose the possible conflicts of interest/Competing Interests they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Conflict of Interest statement should list each author separately by name. The ICMJE has developed a Disclosure Form to facilitate and standardize authors’ disclosures, please click this link to download the ICMJE COI form. Authors are required to upload the duly filled and signed form under the additional files section, during manuscript submission. They can also send it by email to firstname.lastname@example.org. Please follow the link to read the detailed ICMJE recommendations for disclosure of financial and non-financial relationships and activities, and conflicts of interest.
The authors must declare all sources of funding received for the research submitted to the journal. Authors should give the name of granting agencies and grant numbers, along with a short description of each funder’s role. Only the funding related to the submitted work should be mentioned and authors are NOT required to provide the complete list of every single grant that supports them.
ORIGINALITY AND PLAGIARISM
Authors should ensure the originality of their contents while preparing a manuscript draft. In case the authors have used the work and/or words of others this must be appropriately cited or quoted. All the articles submitted to JAPS shall be screened for plagiarism using iThenticate (online plagiarism detection software). In case, plagiarism is detected during the review/editorial process, such manuscript(s) will be rejected immediately. Please read our plagiarism policy for details.
Authors of the original research article must present the accurate data of work performed during their research. Authors are also expected to discuss the objective of their work and the significance of their results. An article should contain sufficient information and references to ensure the reproducibility of the work. Fraudulent or knowingly inaccurate statements considered unethical behavior and are unacceptable.
DATA ACCESS AND RETENTION
Authors may be asked to provide the raw/supplementary data for a paper that is under editorial review. The authors should be prepared to provide the public access to these data (if practicable) and to retain such data for a reasonable time after the publication.
All the manuscripts submitted to JAPS will be subjected to the double-blinded peer-review process. Before starting a submission the authors should make sure that they are aware of our peer-review policy
Patients have a right to privacy thus; all the studies should be conducted with informed consent. No identifying information should be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2013. All the experiments should be approved by the institutional human experimentation committee or equivalent.
Animal experiments must follow the ethical standards for the care and use of laboratory animals. The article involved the animal experiments must seek approval(s) from the appropriate Ethical Committee in accordance with the "Guide for the Care and Use of Laboratory Animals" and ARRIVE guidelines.
Clinical trial registry
Clinical trials must follow the CONSORT guidelines. We advise the authors to register the clinical trials with a clinical trial registry that allows free online access to the public. Registration in the following trial registers is acceptable:
http://www.trialregister.nl/ and http://www.umin.ac.jp/ctr.
Standard abbreviations should be used throughout the manuscript. All nonstandard abbreviations should be kept to a minimum and must be defined in the text following their first use.
Article Processing Charges (APCs)
The authors are required to pay Rs. 6500/- INR (Indian Authors) or USD 200 (foreign authors) for APCs upon acceptance of the manuscript. APCs are applicable only to the accepted articles.
Note: These charges are calculated for a standard length article with 20 pages in MS-Word (1-inch margin each side and two-line space). Additional page charges 250 INR per page (Indian authors) or 8 USD per page (foreign authors) will be applicable for the articles beyond this limit.
Acceptance rate: 12.17 % (May 19 to April 20), Review Time-Frame: 55 Days.
(This data is based on the system generated statistics provided by ejmanager system).